{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T04:16:30Z","timestamp":1783743390768,"version":"3.55.0"},"reference-count":64,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,3,1]]},"DOI":"10.1097\/qai.0b013e318281e772","type":"journal-article","created":{"date-parts":[[2012,12,18]],"date-time":"2012-12-18T09:40:33Z","timestamp":1355823633000},"page":"e61-e69","source":"Crossref","is-referenced-by-count":15,"title":["Attrition From HIV Testing to Antiretroviral Therapy Initiation Among Patients Newly Diagnosed With HIV in Haiti"],"prefix":"10.1097","volume":"62","author":[{"given":"Edva","family":"Noel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morgan","family":"Esperance","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megan","family":"Mclaughlin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel","family":"Bertrand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessy","family":"Devieux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrice","family":"Severe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diessy","family":"Decome","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adias","family":"Marcelin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janet","family":"Nicotera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chris","family":"Delcher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Griswold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Genevive","family":"Meredith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean William","family":"Pape","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serena P.","family":"Koenig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-11-20210131","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1097\/QAI.0b013e3181a44f0a","article-title":". Mortality during the first year of potent antiretroviral therapy in HIV-1-infected patients in 7 sites throughout Latin America and the Caribbean.","volume":"51","author":"Tuboi","year":"2009","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R2-11-20210131","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1111\/j.1365-3156.2008.02078.x","article-title":". Antiretroviral therapy in resource-limited settings 1996 to 2006: patient characteristics, treatment regimens and monitoring in sub-Saharan Africa, Asia and Latin America.","volume":"13","author":"Keiser","year":"2008","journal-title":"Trop Med Int Health"},{"key":"R3-11-20210131","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1097\/QAI.0b013e3181eb4fb9","article-title":". Long-term outcomes of a national expanded access program to antiretroviral therapy: the Chilean AIDS cohort.","volume":"55","author":"Wolff","year":"2010","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R4-11-20210131","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1111\/j.1365-3156.2009.02334.x","article-title":". Five-year experience with scaling-up access to antiretroviral treatment in an HIV care programme in Cambodia.","volume":"14","author":"Thai","year":"2009","journal-title":"Trop Med Int Health"},{"key":"R5-11-20210131","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1097\/QAD.0b013e3282f768f8","article-title":". Rapid scaling-up of antiretroviral therapy in 10,000 adults in Cote dIvoire: 2-year outcomes and determinants.","volume":"22","author":"Toure","year":"2008","journal-title":"AIDS"},{"key":"R6-11-20210131","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1097\/QAD.0b013e328012c54f","article-title":". Response to highly active antiretroviral therapy among severely immuno-compromised HIV-infected patients in Cambodia.","volume":"21","author":"Madec","year":"2007","journal-title":"AIDS"},{"key":"R7-11-20210131","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1097\/QAD.0b013e328333bfb7","article-title":". Seven-year experience of a primary care antiretroviral treatment programme in Khayelitsha, South Africa.","volume":"24","author":"Boulle","year":"2010","journal-title":"AIDS"},{"key":"R8-11-20210131","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1097\/QAI.0b013e3181ff0bdc","article-title":". Changes in programmatic outcomes during 7 years of scale-up at a community-based antiretroviral treatment service in South Africa.","volume":"56","author":"Nglazi","year":"2011","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R9-11-20210131","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/S0140-6736(10)60666-6","article-title":". Prognosis of patients with HIV-1 infection starting antiretroviral therapy in sub-Saharan Africa: a collaborative analysis of scale-up programmes.","volume":"376","author":"May","year":"2010","journal-title":"Lancet"},{"key":"R10-11-20210131","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1001\/jama.296.7.782","article-title":". Rapid scale-up of antiretroviral therapy at primary care sites in Zambia: feasibility and early outcomes.","volume":"296","author":"Stringer","year":"2006","journal-title":"JAMA"},{"key":"R11-11-20210131","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1086\/593312","article-title":". Incidence and predictors of death, retention, and switch to second-line regimens in antiretroviral-treated patients in sub-Saharan African Sites with comprehensive monitoring availability.","volume":"48","author":"Palombi","year":"2009","journal-title":"Clin Infect Dis"},{"key":"R12-11-20210131","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1086\/588673","article-title":". Expanded access to highly active antiretroviral therapy: a potentially powerful strategy to curb the growth of the HIV epidemic.","volume":"198","author":"Lima","year":"2008","journal-title":"J Infect Dis"},{"key":"R13-11-20210131","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/S0140-6736(06)68337-2","article-title":". Mortality of HIV-1-infected patients in the first year of antiretroviral therapy: comparison between low-income and high-income countries.","volume":"367","author":"Braitstein","year":"2006","journal-title":"Lancet"},{"key":"R14-11-20210131","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1097\/01.qai.0000157389.78374.45","article-title":". Effectiveness of highly active antiretroviral therapy in reducing heterosexual transmission of HIV.","volume":"40","author":"Castilla","year":"2005","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R15-11-20210131","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1089\/apc.2009.0286","article-title":". Toward universal access to HIV counseling and testing and antiretroviral treatment in Ethiopia: looking beyond HIV testing and ART initiation.","volume":"24","author":"Assefa","year":"2010","journal-title":"AIDS Patient Care STDS"},{"key":"R16-11-20210131","doi-asserted-by":"crossref","first-page":"e13268","DOI":"10.1371\/journal.pone.0013268","article-title":"Patients present earlier and survival has improved, but pre-ART attrition is high in a six-year HIV cohort data from Ethiopia.","volume":"5","author":"Mulissa","year":"2010","journal-title":"PLoS One"},{"key":"R18-11-20210131","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1111\/j.1365-3156.2007.01830.x","article-title":". Risk factors for treatment denial and loss to follow-up in an antiretroviral treatment cohort in Kenya.","volume":"12","author":"Karcher","year":"2007","journal-title":"Trop Med Int Health"},{"key":"R19-11-20210131","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1097\/QAI.0b013e3181ab73e2","article-title":". Loss to follow-up of adults in public HIV care systems in central Mozambique: identifying obstacles to treatment.","volume":"52","author":"Micek","year":"2009","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R21-11-20210131","doi-asserted-by":"crossref","first-page":"e121","DOI":"10.1371\/journal.pone.0000121","article-title":". Acceptance of anti-retroviral therapy among patients infected with HIV and tuberculosis in rural Malawi is low and associated with cost of transport.","volume":"1","author":"Zachariah","year":"2006","journal-title":"PLoS One"},{"key":"R22-11-20210131","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1097\/QAI.0b013e3181a248e6","article-title":". HIV testing rates and outcomes in a South African community, 2001-2006: implications for expanded screening policies.","volume":"51","author":"April","year":"2009","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"suppl 1","key":"R23-11-20210131","doi-asserted-by":"crossref","first-page":"S37","DOI":"10.1097\/01.aids.0000366081.91192.1c","article-title":". Who starts antiretroviral therapy in Durban, South Africa Not everyone who should.","volume":"24","author":"Bassett","year":"2010","journal-title":"AIDS"},{"key":"R24-11-20210131","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1097\/QAI.0b013e3181a44ef2","article-title":". Loss to care and death before antiretroviral therapy in Durban, South Africa.","volume":"51","author":"Bassett","year":"2009","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R25-11-20210131","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1097\/QAD.0b013e32830ebcee","article-title":". Loss to follow-up and mortality among pregnant women referred to a community clinic for antiretroviral treatment.","volume":"22","author":"Kaplan","year":"2008","journal-title":"AIDS"},{"key":"R26-11-20210131","doi-asserted-by":"crossref","first-page":"2717","DOI":"10.1097\/QAD.0b013e32833fb71f","article-title":". Outcomes in patients waiting for antiretroviral treatment in the Free State Province, South Africa: prospective linkage study.","volume":"24","author":"Ingle","year":"2010","journal-title":"AIDS"},{"key":"R27-11-20210131","doi-asserted-by":"crossref","first-page":"e13801","DOI":"10.1371\/journal.pone.0013801","article-title":". Linkage to HIV care and antiretroviral therapy in Cape Town, South Africa.","volume":"5","author":"Kranzer","year":"2010","journal-title":"PLoS One"},{"key":"R28-11-20210131","doi-asserted-by":"crossref","first-page":"675","DOI":"10.2471\/BLT.09.068981","article-title":". Lost opportunities to complete CD4 lymphocyte testing among patients who tested positive for HIV in South Africa.","volume":"88","author":"Larson","year":"2010","journal-title":"Bull World Health Organ"},{"issue":"suppl 1","key":"R29-11-20210131","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1111\/j.1365-3156.2010.02511.x","article-title":". Early loss to follow up after enrolment in pre-ART care at a large public clinic in Johannesburg, South Africa.","volume":"15","author":"Larson","year":"2010","journal-title":"Trop Med Int Health"},{"key":"R30-11-20210131","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1086\/507095","article-title":". Determinants of mortality and nondeath losses from an antiretroviral treatment service in South Africa: implications for program evaluation.","volume":"43","author":"Lawn","year":"2006","journal-title":"Clin Infect Dis"},{"key":"R31-11-20210131","doi-asserted-by":"crossref","first-page":"e79","DOI":"10.1097\/QAI.0b013e3182075ae2","article-title":". Retention in HIV care for individuals not yet eligible for antiretroviral therapy: rural KwaZulu-Natal, South Africa.","volume":"56","author":"Lessells","year":"2011","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R32-11-20210131","doi-asserted-by":"crossref","first-page":"e9538","DOI":"10.1371\/journal.pone.0009538","article-title":". The ART of linkage: pre-treatment loss to care after HIV diagnosis at two PEPFAR sites in Durban, South Africa.","volume":"5","author":"Losina","year":"2010","journal-title":"PLoS One"},{"key":"R33-11-20210131","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1186\/1471-2458-9-290","article-title":". Mortality and loss-to-follow-up during the pre-treatment period in an antiretroviral therapy programme under normal health service conditions in Uganda.","volume":"9","author":"Amuron","year":"2009","journal-title":"BMC Public Health"},{"key":"R34-11-20210131","doi-asserted-by":"crossref","first-page":"2141","DOI":"10.1097\/01.aids.0000194802.89540.e1","article-title":". Early mortality among adults accessing a community-based antiretroviral service in South Africa: implications for programme design.","volume":"19","author":"Lawn","year":"2005","journal-title":"AIDS"},{"key":"R35-11-20210131","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1186\/1471-2458-10-601","article-title":". What happens to ART-eligible patients who do not start ART Dropout between screening and ART initiation: a cohort study in Karonga, Malawi.","volume":"10","author":"McGrath","year":"2010","journal-title":"BMC Public Health"},{"key":"R37-11-20210131","doi-asserted-by":"crossref","first-page":"e19484","DOI":"10.1371\/journal.pone.0019484","article-title":". Barriers to initiation of antiretrovirals during antituberculosis therapy in Africa.","volume":"6","author":"Pepper","year":"2011","journal-title":"PLoS One"},{"issue":"suppl 1","key":"R38-11-20210131","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1111\/j.1365-3156.2010.02504.x","article-title":". Vital status of pre-ART and ART patients defaulting from care in rural Malawi.","volume":"15","author":"McGuire","year":"2010","journal-title":"Trop Med Int Health"},{"key":"R40-11-20210131","doi-asserted-by":"crossref","first-page":"e1001056","DOI":"10.1371\/journal.pmed.1001056","article-title":"Retention in HIV care between testing and treatment in sub-Saharan Africa: a systematic review.","volume":"8","author":"Rosen","year":"2011","journal-title":"PLoS Med"},{"key":"R41-11-20210131","doi-asserted-by":"crossref","first-page":"e60","DOI":"10.1097\/QAI.0b013e318245d3c1","article-title":". Long-term antiretroviral treatment outcomes in seven countries in the Caribbean.","volume":"59","author":"Koenig","year":"2012","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R42-11-20210131","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1097\/01.aids.0000206505.09159.9a","article-title":". Multidrug-resistant tuberculosis at an HIV testing center in Haiti.","volume":"20","author":"Joseph","year":"2006","journal-title":"AIDS"},{"key":"R44-11-20210131","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1111\/j.1365-3156.2012.03055.x","article-title":"Defining retention and attrition in pre-antiretroviral HIV care: proposals based on experience in Africa.","volume":"17","author":"Fox","year":"2012","journal-title":"Trop Med Int Health"},{"key":"R45-11-20210131","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1258\/ijsa.2011.010442","article-title":". Enrolment and programmatic trends and predictors of antiretroviral therapy initiation from presidents emergency plan for AIDS Relief (PEPFAR)-supported public HIV care and treatment sites in rural Mozambique.","volume":"22","author":"Moon","year":"2011","journal-title":"Int J STD AIDS"},{"key":"R46-11-20210131","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/s11904-005-0012-8","article-title":"Antiretroviral adherence in a resource-poor setting.","volume":"2","author":"Orrell","year":"2005","journal-title":"Curr HIVAIDS Rep"},{"key":"R47-11-20210131","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1080\/09540120802385629","article-title":". Doubts, denial and divine intervention: understanding delayed attendance and poor retention rates at a HIV treatment programme in rural Tanzania.","volume":"21","author":"Wringe","year":"2009","journal-title":"AIDS Care"},{"key":"R48-11-20210131","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/1758-2652-12-31","article-title":". From HIV diagnosis to treatment: evaluation of a referral system to promote and monitor access to antiretroviral therapy in rural Tanzania.","volume":"12","author":"Nsigaye","year":"2009","journal-title":"J Int AIDS Soc"},{"key":"R49-11-20210131","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1097\/QAI.0b013e31814277c8","article-title":". Routine voluntary HIV testing in Durban, South Africa: the experience from an outpatient department.","volume":"46","author":"Bassett","year":"2007","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R50-11-20210131","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1007\/s11904-010-0061-5","article-title":". Retention in care among HIV-infected patients in resource-limited settings: emerging insights and new directions.","volume":"7","author":"Geng","year":"2010","journal-title":"Curr HIVAIDS Rep"},{"key":"R51-11-20210131","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1007\/s10461-007-9293-9","article-title":". Assessing social preparedness for antiretroviral therapy in a generalized AIDS epidemic: a diffusion of innovations approach.","volume":"13","author":"Mitchell","year":"2009","journal-title":"AIDS Behav"},{"key":"R52-11-20210131","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1097\/QAD.0b013e3283383aeb","article-title":". Testing but not treating: missed opportunities and lost lives in the South African antiretroviral therapy programme.","volume":"24","author":"Jarvis","year":"2010","journal-title":"AIDS"},{"key":"R53-11-20210131","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1097\/QAD.0b013e32832a5996","article-title":". Delayed first consultation after diagnosis of HIV infection in Cameroon.","volume":"23","author":"Marcellin","year":"2009","journal-title":"AIDS"},{"key":"R54-11-20210131","doi-asserted-by":"crossref","first-page":"e87","DOI":"10.1097\/QAI.0b013e31822f064e","article-title":". Barriers to antiretroviral initiation in HIV-1-discordant couples.","volume":"58","author":"Guthrie","year":"2011","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R55-11-20210131","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1080\/09540120701513677","article-title":". Reasons for unsatisfactory acceptance of antiretroviral treatment in the urban Kibera slum, Kenya.","volume":"20","author":"Unge","year":"2008","journal-title":"AIDS Care"},{"key":"R56-11-20210131","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1016\/S0140-6736(06)68580-2","article-title":". Scaling up of highly active antiretroviral therapy in a rural district of Malawi: an effectiveness assessment.","volume":"367","author":"Ferradini","year":"2006","journal-title":"Lancet"},{"key":"R57-11-20210131","doi-asserted-by":"crossref","first-page":"2303","DOI":"10.1097\/QAD.0b013e3283129db0","article-title":". Five-year outcomes of initial patients treated in Botswanas National Antiretroviral Treatment Program.","volume":"22","author":"Bussmann","year":"2008","journal-title":"AIDS"},{"key":"R58-11-20210131","doi-asserted-by":"crossref","first-page":"e18453","DOI":"10.1371\/journal.pone.0018453","article-title":". Four-year treatment outcomes of adult patients enrolled in Mozambiques rapidly expanding antiretroviral therapy program.","volume":"6","author":"Auld","year":"2011","journal-title":"PLoS One"},{"key":"R59-11-20210131","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1097\/01.aids.0000226959.87471.01","article-title":". Mortality and causes of death in adults receiving highly active antiretroviral therapy in Senegal: a 7-year cohort study.","volume":"20","author":"Etard","year":"2006","journal-title":"AIDS"},{"issue":"suppl 1","key":"R60-11-20210131","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-3156.2010.02508.x","article-title":"Patient retention in antiretroviral therapy programs up to three years on treatment in sub-Saharan Africa, 2007-2009: systematic review.","volume":"15","author":"Fox","year":"2010","journal-title":"Trop Med Int Health"},{"key":"R61-11-20210131","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1056\/NEJMc0809485","article-title":". 5-Year survival of patients with AIDS receiving antiretroviral therapy in Haiti.","volume":"361","author":"Leger","year":"2009","journal-title":"N Engl J Med"},{"key":"R62-11-20210131","doi-asserted-by":"crossref","first-page":"e298","DOI":"10.1371\/journal.pmed.0040298","article-title":"Patient retention in antiretroviral therapy programs in sub-Saharan Africa: a systematic review.","volume":"4","author":"Rosen","year":"2007","journal-title":"PLoS Med"},{"key":"R63-11-20210131","doi-asserted-by":"crossref","first-page":"681","DOI":"10.2471\/BLT.09.064329","article-title":". Influence of gender on loss to follow-up in a large HIV treatment programme in western Kenya.","volume":"88","author":"Ochieng-Ooko","year":"2010","journal-title":"Bull World Health Organ"},{"key":"R64-11-20210131","doi-asserted-by":"crossref","first-page":"2325","DOI":"10.1056\/NEJMoa051908","article-title":". Antiretroviral therapy in a thousand patients with AIDS in Haiti.","volume":"353","author":"Severe","year":"2005","journal-title":"N Engl J Med"},{"key":"R65-11-20210131","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1056\/NEJMoa0910370","article-title":". Early versus standard antiretroviral therapy for HIV-infected adults in Haiti.","volume":"363","author":"Severe","year":"2010","journal-title":"N Engl J Med"},{"key":"R66-11-20210131","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1111\/j.1365-3156.2012.02958.x","article-title":". Linking women who test HIV-positive in pregnancy-related services to long-term HIV care and treatment services: a systematic review.","volume":"17","author":"Ferguson","year":"2012","journal-title":"Trop Med Int Health"},{"key":"R68-11-20210131","doi-asserted-by":"crossref","first-page":"970","DOI":"10.2471\/BLT.07.050120","article-title":". Survival, plasma HIV-1 RNA concentrations and drug resistance in HIV-1-infected Haitian adolescents and young adults on antiretrovirals.","volume":"86","author":"Charles","year":"2008","journal-title":"Bull World Health Organ"},{"key":"R69-11-20210131","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1086\/421521","article-title":". Virologic and immunologic outcomes after 24 weeks in HIV type 1-infected adolescents receiving highly active antiretroviral therapy.","volume":"190","author":"Flynn","year":"2004","journal-title":"J Infect Dis"},{"key":"R70-11-20210131","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1001\/archpedi.159.8.764","article-title":". Longitudinal antiretroviral adherence among adolescents infected with human immunodeficiency virus.","volume":"159","author":"Murphy","year":"2005","journal-title":"Arch Pediatr Adolesc Med"}],"container-title":["JAIDS Journal of Acquired Immune Deficiency Syndromes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/QAI.0b013e318281e772","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T05:58:36Z","timestamp":1620971916000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00126334-201303010-00011"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,3,1]]},"references-count":64,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.1097\/qai.0b013e318281e772","relation":{},"ISSN":["1525-4135"],"issn-type":[{"value":"1525-4135","type":"print"}],"subject":[],"published":{"date-parts":[[2013,3,1]]}}}